Topical calcineurin inhibitors in eczema and cancer association: A cohort study.

about

Atopic Eczema: Genetic Associations and Potential Links to Developmental Exposures.

P2860

Q50448143-E567FE8F-8301-48D5-AD0D-E500F642EA61

P2860

Topical calcineurin inhibitors in eczema and cancer association: A cohort study.

Item

http://www.wikidata.org/entity/Q39859545

description

2016 nî lūn-bûn

@nan

2016年の論文

@ja

2016年論文

@yue

2016年論文

@zh-hant

2016年論文

@zh-hk

2016年論文

@zh-mo

2016年論文

@zh-tw

2016年论文

@wuu

2016年论文

@zh

2016年论文

@zh-cn

name

Topical calcineurin inhibitors in eczema and cancer association: A cohort study.

@en

Topical calcineurin inhibitors in eczema and cancer association: A cohort study.

@nl

type

Item

label

Topical calcineurin inhibitors in eczema and cancer association: A cohort study.

@en

Topical calcineurin inhibitors in eczema and cancer association: A cohort study.

@nl

prefLabel

Topical calcineurin inhibitors in eczema and cancer association: A cohort study.

@en

Topical calcineurin inhibitors in eczema and cancer association: A cohort study.

@nl

P1476

Topical calcineurin inhibitors in eczema and cancer association: A cohort study.

@en

P2093

E A L Tian

http://www.w3.org/2001/XMLSchema#string

H L Tey

http://www.w3.org/2001/XMLSchema#string

J C Allen

http://www.w3.org/2001/XMLSchema#string

S C S Cai

http://www.w3.org/2001/XMLSchema#string

W Li

http://www.w3.org/2001/XMLSchema#string

P2860

The carcinogenic potential of tacrolimus ointment beyond immune suppression: a hypothesis creating case report.

Inherent calcineurin inhibitor FKBP38 targets Bcl-2 to mitochondria and inhibits apoptosis

FK506 prevents mitochondrial-dependent apoptotic cell death induced by 3-nitropropionic acid in rat primary cortical cultures.

Eczema drugs tacrolimus (Protopic) and pimecrolimus (Elidel): cancer concerns.

Percutaneous absorption of drugs used in atopic eczema: pimecrolimus permeates less through skin than corticosteroids and tacrolimus.

Topical noncorticosteroid immunomodulation in the treatment of atopic dermatitis.

Calcineurin inhibitors and sirolimus: mechanisms of action and applications in dermatology.

Association Between Malignancy and Topical Use of Pimecrolimus.

Topical calcineurin inhibitors and lymphoma risk: evidence update with implications for daily practice.

Immortal time bias in pharmaco-epidemiology.

P304

531-537

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.3109/09546634.2016.1163317

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2016-04-06T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

27049893

http://www.w3.org/2001/XMLSchema#string

Topical calcineurin inhibitors in eczema and cancer association: A cohort study.

about

P2860

P2860

Topical calcineurin inhibitors in eczema and cancer association: A cohort study.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P577

P698

P356

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P577

P698